. These results suggest that PD-L1 on EVs may be another mechanism for glioblastoma to suppress antitumor immunity and support the potential of EVs as biomarkers in tumor patients.
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles | Litlas